How big is the Europe Organ Preservation Market?

The Europe Organ Preservation Market size is expected to reach USD 69.49 million in 2024 and grow at a CAGR of 6.48% to reach USD 95.10 million by 2029. Read More

What is the current Europe Organ Preservation Market size?

In 2024, the Europe Organ Preservation Market size is expected to reach USD 69.49 million. Read More

Who are the key players in Europe Organ Preservation Market?

Bridge to Life Ltd, Franz Koehler Chemie GmbH, OrganOx Limited, Paragonix Technologies, Inc and Intas Pharmaceuticals (Accord Healthcare) are the major companies operating in the Europe Organ Preservation Market. Read More

What years does this Europe Organ Preservation Market cover, and what was the market size in 2023?

In 2023, the Europe Organ Preservation Market size was estimated at USD 64.99 million. The report covers the Europe Organ Preservation Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Organ Preservation Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe Organ Preservation Market Size & Share Analysis - Industry Research Report

Europe Organ Preservation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Europe Organ Preservation Market Reportis Segmented by Technique (Static Cold Storage [SCS] Technique, Hypothermic Machine Perfusion, Normothermic Machine Perfusion), Product Type (Preservation Solutions, Transport Systems, and Other Product Types), Organ Type (Kidneys, Liver, Lung, Heart, and Other Organ Types), and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). The Report Offers the Value (USD) for the Above Segments.

Europe Organ Preservation Industry Overview

The European organ preservation market is semi-consolidated in nature and consists of several major players. Some of the major players have used various strategies such as expansions, agreements, new product launches, joint ventures, acquisitions, and partnerships to increase their footprints in this market. Some of the key players in the market are Intas Pharmaceuticals (Accord Healthcare), Bridge to Life Ltd, Franz Koehler Chemie GmbH, OrganOx Limited, and Paragonix Technologies Inc.